(Q44156425)

30 November 2017

title

Selective deficits in Alzheimer and parkinsonian dementia: visuospatial function (English)

1 reference

30 November 2017

Selective Deficits in Alzheimer and Parkinsonian Dementia: Visuospatial Function (English)

0 references

0 references

1 reference

1 reference

2

Irene Litvan

Litvan I

1 reference

30 November 2017

Erich Mohr

1

1 reference

30 November 2017

Jill Williams

series ordinal

3

1 reference

30 November 2017

Paul Fedio

series ordinal

4

1 reference

30 November 2017

Thomas N. Chase

series ordinal

5

1 reference

30 November 2017

publication date

1 August 1990

1 reference

30 November 2017

August 1990

0 references

number of pages

6

1 reference

Canadian Journal of Neurological Sciences

inferred from page(s)

published in

1 reference

30 November 2017

volume

17

1 reference

30 November 2017

issue

3

1 reference

30 November 2017

03

0 references

page(s)

292-297

1 reference

A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030596

7 January 2021

Dopamine and memory function in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030596

7 January 2021

'Subcortical dementia': the neuropsychological evidence

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030596

7 January 2021

Dementia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030596

7 January 2021

Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030596

7 January 2021

Cholinergic-dependent cognitive deficits in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030596

7 January 2021

Cortical glucose utilization patterns in primary degenerative dementias of the anterior and posterior type

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030596

7 January 2021

Norepinephrine Biosynthesis Inhibition: Effects on Memory in Mice

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030596

7 January 2021

Cognitive concomitants of dopamine system stimulation in parkinsonian patients

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030596

7 January 2021

Dementia in Parkinson disease: A neuropathologic study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030596

7 January 2021

Pathologic correlates of dementia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030596

7 January 2021

Cognitive and motor dysfunction in Parkinson's disease. Clinical, performance, and computed tomographic correlations

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030596

7 January 2021

Visuospatial impairment in Parkinson's disease. Role of perceptual and motor factors

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030596

7 January 2021

Visuospatial function in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030596

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030596

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030596

7 January 2021

Muscarinic agonist therapy of Alzheimer's disease. A clinical trial of RS-86.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030596

7 January 2021

Differential Perceptual-Spatial Impairment in Huntington's and Alzheimer's Dementias

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030596

7 January 2021

Alzheimer's disease and Parkinson's disease: Comparison of speech and language alterations

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030596

7 January 2021

'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030596

7 January 2021

Rapidly progressive Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030596

7 January 2021

Changes in the brain catecholamines in patients with dementia of Alzheimer type.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030596

7 January 2021

Non-cholinergic neurotransmitter abnormalities in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030596

7 January 2021

Parkinson's disease and dementia: norepinephrine and dopamine in locus ceruleus

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030596

7 January 2021

Memory enhancement by central administration of norepinephrine

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030596

7 January 2021

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030596

7 January 2021

The cholinergic hypothesis--ten years on.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030596

7 January 2021

Dementia in movement disorders.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030596

7 January 2021

Parkinson disease, dementia, and Alzheimer disease: clinicopathological correlations.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030596

7 January 2021

Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100030596

7 January 2021

10.1017/S0317167100030596

Identifiers

DOI

0 references

1 reference